Human
APIS

Experts in developing
high quality pharmaceutical active ingredients

We develop, produce and market active ingredients for pharmaceutical and biotechnological industries to more than 70 countries and 3,000 clients.

Our wide experience backs us up

Contact us and we will provide you with details of our extensive product portfolio.

Strategic
APIS

  • MINOCYCLINE HCl – Antibiotic
  • LYMECYCLINE – Antibiotic
  • TETRACYCLINE HCl – Antibiotic
  • RIVAROXABAN – Anticoagulant
  • CLOMIPHENE CITRATE – Fertility
  • OXYTETRACYCLINE Ca – Antibiotic
  • CLOBUTINOL HCl – Antitussive
  • ANASTROZOLE – Oncology
  • BISOPROLOL FUMARATE – Antihypertensive
  • ENOXAPARINE SODIUM – Anticoagulant
  • PIPERACILLIN + TAZOBACTAM – Antibiotic
  • TRIMEBUTINE MALEATE – Antiemetic
  • VALSARTAN – Antihypertensive
  • GABAPENTIN – Antiepileptics
  • IMATINIB MESYLATE – Oncology
  • COLISTIMETHATE SODIUM – Antibiotic
  • QUETIAPINE FUMARATE – Antipsychotic
  • MUPIROCIN Ca – Antibiotic

Research
& Development

API

USO

LANZAMIENTO GENÉRICO ESPERADO EN EUROPA

APIXABANANTICOAGULANTEMAYO 26
BOSUTINIBONCOLOGÍAENERO - 28
COBICISTATANTIRETROVIRALSEPTIEMBRE - 24
DOLUTEGAVIR SÓDICOANTIRETROVIRALENERO - 29
ENZALUTAMIDAONCOLOGÍADICIEMBRE - 24
MIRABEGRONUROLOGÍAJUNIO - 28
SELEXIPAGHIPERTENSIÓN
PULMONAR
ABRIL - 29
TICAGRELORAGENTE ANTIPLAQUETARIOOCTUBRE - 27
UMECLIDINIUM BROMUROEPOCNOVIEMBRE - 26
VORTIOXETINAANTIDEPRESIVOABRIL - 27

Other products developed
& manufactured under exclusive basis

Specialized products with studies
and available clinical data

If you can´t find the product you are looking for,
or you are interested in developing a new product,
please contact us.

+34 91 344 68 90
info@suanfarma.com